Kandemir Baş

Dr. Kandemir Baş

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

17 February 2026
Verified
Book
Closed access
SASeda Altuntaş
Seda Altuntaş
MRMehmet Rum
Mehmet Rum
ZCZeki Cetinkaya
Zeki Cetinkaya
FÖFerih Özcanlı
Ferih Özcanlı
GTGÜLŞEN GENÇ TAPAR
GÜLŞEN GENÇ TAPAR
FBFERIT BOYUK
FERIT BOYUK

11 August 2025
Verified
Book Chapter
Closed access
RARezan Aksoy
Rezan Aksoy
KBKandemir Baş
Kandemir Baş
This chapter examines minimally invasive mitral valve surgery techniques. Right mini-thoracotomy is the most commonly used approach for mitral valve repair, utilizing small incisions and video-assisted surgery. Patient selection depends on surgical risks and the complexity of mitral valve pathology. Minimally invasive mitral valve surgery offers benefits like reduced pain, faster recovery, and lower infection risk. Bu bölüm, minimal invaziv mitral kapak cerrahisinin yöntemlerini ele almaktadır. Sağ mini-torakotomi, mitral kapak tamiri için en yaygın tercih edilen tekniktir. Bu yöntem, küçük insizyonlar ve video destekli cerrahi kullanılarak gerçekleştirilir. Hasta seçimi, cerrahi riskler ve mitral kapak patolojisinin karmaşıklığına göre yapılmalıdır. Minimal invaziv mitral kapak cerrahisi, daha az ağrı, kısa iyileşme süresi ve daha düşük enfeksiyon riski sunar.

20 June 2026 in Genes
Verified
Journal Article
Open access
PDF file
RÇRecep Çalışkan
Recep Çalışkan
EKEren Osman Karpuzoglu
Eren Osman Karpuzoglu
FKFatma Hande Karpuzoğlu
Fatma Hande Karpuzoğlu
CKCanan Kucukgergin
Canan Kucukgergin
KBKandemir Baş
Kandemir Baş
CKCevdet Uğur Koçoğulları
Cevdet Uğur Koçoğulları
Objective: To evaluate the efficacy of NADPH oxidase 4 and miR-146a-5p in current treatment planning for ascending aortic aneurysms, independent of aortic diameter, and to develop protocols that will ensure the treatment of ascending aortic aneurysms, which pose a risk for aortic dissection, without complications. Methods: Patients who met the inclusion criteria and underwent surgery at Dr. Siyami Ersek Chest, Heart, and Vascular Surgery Training and Research Hospital for ascending aortic aneurysms and coronary artery disease between 2023 and 2024 were included in the study. This study was designed as a prospective study. Demographic, biochemical, radiological, and echocardiographic data were collected, and NOX4 mRNA and miR-146a-5p expressions were examined and compared in tissue samples. Results: The study was conducted on a total of 50 patients, with 25 patients in the aneurysm group and 25 patients in the control group. miR-146a-5p expression levels were found to be significantly decreased in the patient group compared to the control group (p = 0.001). When NOX4 mRNA expression levels were examined, no significant difference was found between the control and aneurysm groups. No correlation was found between NOX4 mRNA and miR-146a-5p levels (p = 0.764). When the relationship between ascending aorta diameter and both NOX4 mRNA and miR-146a-5p was examined, it was found that miR-146a-5p expression was negatively correlated with ascending aorta diameter (p = 0.036) and did not show a significant correlation with NOX4 mRNA levels (p = 0.318). A similar correlation was also found with ascending aorta length. The correlation of NOX4 mRNA and miR-146a-5p expression levels with age, gender, and ejection fraction was investigated separately. No significant correlation was found for all three variables. The optimum cut-off value to be used to separate the patient group from the control group using miR-146a-5p expression levels, as well as the sensitivity and specificity of miR-146a-5p expression levels when this cut-off value was used, was calculated using an ROC curve. Specificity for miR-146a-5p expression was found to be 88%, and sensitivity was found to be 66%. Conclusions: The study found promising results indicating that NOX4, shown to be a determinant of vascular oxidative stress, is not involved in the development of ascending aortic aneurysms; however, miR-146a-5p, which functions in the regulation of many inflammatory responses, including the regulation of NOX4 expression, may help prevent the development of ascending aortic aneurysms. Further studies aimed at elucidating the genetic and biochemical processes involved in aneurysm development suggest that miR-146a-5p could be a therapeutic target for preventing aneurysms.

11 August 2025
Verified
Book
Open access
PDF file
MŞMustafa Şimşek
Mustafa Şimşek
UKUğur Kısa
Uğur Kısa
KBKandemir Baş
Kandemir Baş
OEOkan Ersan
Okan Ersan
EKEren Osman Karpuzoglu
Eren Osman Karpuzoglu
EKErsin Kadirogulları
Ersin Kadirogulları
Getting Started With Minimally Invasive Cardiac Surgery Barış TİMUR Cevdet Uğur KOÇOGULLARI Anesthetic Management in Minimally Invasive Cardiac Surgery Mustafa ŞİMŞEK Minimally Invasive Aortic Valve Surgery Uğur KISA Naci Cem AYDOĞDU Minimally Invasive Mitral Valve Surgery Rezan AKSOY Kandemir BAS Minimal Invasive Transcatheter Mitral Valve Interventions Rezan AKSOY Okan ERSAN Minimally Invasive Multi-Valve Surgery Osman Eren KARPUZOĞLU Recep ÇALIŞKAN Minimally Invasive Tricuspid Valve Surgery Osman Eren KARPUZOĞLU Mustafa İMRE Minimally Invasive Congenital Cardiac Surgery Murat ÇİÇEK Minimally Invasive Coronary Arter Bypass Grafting Cevdet Uğur KOÇOĞULLARI Yiğit KÖSE Recep ÇALISKAN Ferhat TÜMKAYA Minimally İnvasive Surgical Methods for The Treatment of Atrial Fibrillation Ünsal VURAL Ahmet Arif AGLAR Robotic Cardiac Surgery Murat Bülent RABUS Ersin KADIROGULLARI

1 July 2025 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
BTBarış Timur
Barış Timur
RARezan Aksoy
Rezan Aksoy
ZDZihni Mert Duman
Zihni Mert Duman
RÇRecep Çalışkan
Recep Çalışkan
KBKandemir Baş
Kandemir Baş
CKCevdet Ugur Kocogullari
Cevdet Ugur Kocogullari
This study explores the impact of left ventricular mass and geometry on the prognosis of patients undergoing coronary artery bypass grafting. Left ventricular hypertrophy is a known risk factor for cardiovascular complications, yet its role in surgical outcomes remains underexplored.A retrospective cohort of 494 elective coronary artery bypass grafting patients treated between 2013 and 2018 was analyzed. Left ventricular mass was calculated using the Devereux formula, and patients were divided into normal and increased left ventricular mass index groups. Mortality rates, postoperative complications, and echocardiographic parameters were evaluated.Patients with increased left ventricular mass exhibited significantly higher 5-year mortality rates (27.2 vs. 11.5%, p < 0.001), postoperative atrial fibrillation (24.8 vs. 16.0%, p = 0.018), and carotid stenosis (21.8 vs. 12.5%, p = 0.006). Elevated preoperative biomarkers, including creatinine and C-reactive protein, were observed in this group, with sustained impairment in postoperative kidney function. However, no significant differences in 30-day, 1-year, or 3-year mortality rates were detected.Left ventricular mass and geometry independently predict long-term outcomes in coronary artery bypass grafting patients. Targeted strategies to mitigate left ventricular remodeling may enhance postoperative outcomes. Future research should focus on therapeutic interventions to reverse adverse left ventricular changes and optimize patient survival and quality of life.